Lite Strategy, Inc. 8K

Lite Strategy, Inc. announced fiscal Q2 2026 results featuring new active LTC-based treasury operations, a $25 million share repurchase program, and ongoing pharmaceutical R&D activities for potential partnering or monetization.

On February 17, 2026, Lite Strategy, Inc. reported its fiscal 2026 second quarter results, highlighting the successful launch of an active treasury management program that generated approximately $600,000 in covered call option premiums on its Litecoin (LTC) holdings, initiation of a $25 million stock repurchase program funded by these treasury operations, and the start of pre-clinical R&D activities in its pharmaceutical pipeline for potential out-licensing or sale, while noting it held $8.8 million in cash and cash equivalents as of December 31, 2025 and plans to continue working with crypto investment firm GSR on further treasury, repurchase, and strategic investment initiatives.

Filing Facts

CIK

1262104

Ticker

-

Form

8K

Source Type

sec

Accession

0001193125-26-053243

Alert Tier

6